| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.79B | -9.4% | +16.8% |
| Cost of Revenue | $2.17B | -2.7% | +23.7% |
| Gross Profit | $1.63B | -17.0% | +8.7% |
| R&D Expense | $275.0M | +7.4% | +29.1% |
| SG&A Expense | $702.0M | +33.7% | +60.3% |
| Operating Income | -$834.0M | -314.4% | -959.8% |
| Interest Expense | $167.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.73B | +2.1% | +16.5% |
| Accounts Receivable | $158.0M | -1.9% | +81.6% |
| Current Assets | $4.78B | +8.8% | +14.7% |
| Total Assets | $29.34B | -1.8% | +15.1% |
| Current Liabilities | $4.96B | +7.3% | +5.4% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $756.0M | — | — |
| Capital Expenditures | $69.0M | — | — |
| Investing Cash Flow | -$3.13B | — | — |
| Financing Cash Flow | $2.52B | — | — |
| Free Cash Flow | $687.0M | — | — |
| +30.5% |
| +35.8% |
| Pre-tax Income | -$834.0M | -506.8% | -541.5% |
| Income Tax | -$45.0M | -126.8% | -181.3% |
| Net Income | -$789.0M | -2232.4% | -592.1% |
| EPS (Basic) | -$3.91 | -762.7% | -574.1% |
| EPS (Diluted) | -$3.91 | -762.7% | -574.1% |
| $12.10B |
| +21.6% |
| +75.1% |
| Total Liabilities | $19.42B | +12.7% | +44.2% |
| Stockholders' Equity | $9.24B | -9.5% | -9.8% |